Epoprostenol

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14518 publications

Treprostinil Inhalation Powder for Pulmonary Arterial Hypertension: Evidence and Clinical Positioning Among Inhaled Formulations.

Treprostinil Inhalation Powder for Pulmonary Arterial Hypertension: Evidence and Clinical Positioning Among Inhaled Formulations.

Journal: The Annals of pharmacotherapy

Published: October 30, 2026

Endothelial mechanosensitive transcription factor NR4A1 induced by Piezo1 modulates thrombosis via PTGS2.

Endothelial mechanosensitive transcription factor NR4A1 induced by Piezo1 modulates thrombosis via PTGS2.

Journal: Journal of molecular cell biology

Published: October 24, 2026

Treatment Strategies for Achieving and Maintaining Low-Risk Status in Pulmonary Arterial Hypertension: A Systematic Review.

Treatment Strategies for Achieving and Maintaining Low-Risk Status in Pulmonary Arterial Hypertension: A Systematic Review.

Journal: Cureus

Published: October 18, 2026

Physiology-Guided Management of Acute Right Ventricular Failure and Pulmonary Hypertension in Critically Ill Patients: Hemodynamic Phenotypes, Ventilator Interactions, and Rescue Strategies.

Physiology-Guided Management of Acute Right Ventricular Failure and Pulmonary Hypertension in Critically Ill Patients: Hemodynamic Phenotypes, Ventilator Interactions, and Rescue Strategies.

Journal: Medical sciences (Basel, Switzerland)

Published: October 03, 2026

Real-world analysis on hemodynamic effectiveness and adverse events of selexipag in pulmonary arterial hypertension.

Real-world analysis on hemodynamic effectiveness and adverse events of selexipag in pulmonary arterial hypertension.

Journal: Therapeutic advances in respiratory disease

Published: September 29, 2026

Unusual Vascular Claudication in a Seronegative Patient: Raynaud's Phenomenon or Atypical Buerger Disease.

Unusual Vascular Claudication in a Seronegative Patient: Raynaud's Phenomenon or Atypical Buerger Disease.

Journal: Cureus

Published: September 10, 2026

Real-World Experience of Midodrine in Hospital Setting in Pulmonary Arterial Hypertension.

Real-World Experience of Midodrine in Hospital Setting in Pulmonary Arterial Hypertension.

Journal: CHEST pulmonary

Published: September 03, 2026

Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review.

Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 02, 2026

Women in healthy transition deep phenotyping cohort study protocol (KiSO-DP): a within-participant multidisciplinary longitudinal cohort study across the menopausal transition.

Women in healthy transition deep phenotyping cohort study protocol (KiSO-DP): a within-participant multidisciplinary longitudinal cohort study across the menopausal transition.

Journal: BMJ open

Published: August 20, 2026

Efficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Journal: Advances in respiratory medicine

Published: August 19, 2026

Transcatheter atrial flow regulator implantation in children with pulmonary arterial hypertension in resource-limited settings: a single-centre experience.

Transcatheter atrial flow regulator implantation in children with pulmonary arterial hypertension in resource-limited settings: a single-centre experience.

Journal: Cardiology in the young

Published: August 10, 2026

Inhaled pulmonary vasodilators in pulmonary hypertension: Perioperative use and clinical considerations.

Inhaled pulmonary vasodilators in pulmonary hypertension: Perioperative use and clinical considerations.

Journal: JHLT open

Published: August 10, 2026

Showing 1-12 of 14,518

Last Updated: 11/08/2026